Obulytix is developing a revolutionary solution for antibiotic resistance
Spin-off has built a platform that creates new ways to tackle bacterial infections
11-Dec-2023 -
Obulytix, a groundbreaking biotech spin-off founded by seasoned experts in phage lysin research from Ghent University and KU Leuven, is set to revolutionize the fight against antimicrobial resistance with its novel phage lysin-based antibiotics. The innovative, phage lysin-based platform – ...
anti-infectives
antibiotic resistance
antibiotics
+7